Everolimus (RAD001) Assay Workflow for Cancer Research
2026-09-07
Build more informative mTOR studies with Everolimus (RAD001), combining proliferation, signaling, and cell-death measurements rather than relying on a single viability endpoint. This workflow helps distinguish cytostatic responses from true killing across cancer cell and translational models.
QX77 for Reliable Autophagy Assays
2026-09-05
This scenario-driven guide explains how QX77 (SKU BA3596) can support reproducible chaperone-mediated autophagy research, stem cell biology research, and viability workflows. It connects product handling, assay controls, interpretation, and vendor-selection decisions with current mechanistic evidence while clearly separating documented specifications from practical recommendations.
Piezo1, Stiffness, and DRG Axon Regeneration
2026-09-05
The 2024 Advanced Science study identifies substrate stiffness as a regulator of dorsal root ganglion axon regrowth and places Piezo1 at the center of a Ca2+–CaMKII–FAK–actin signaling cascade. Its combination of stiffness-controlled cultures with adult sciatic nerve injury experiments links mechanotransduction to cytoskeletal remodeling and functional sensory recovery.
Periostin Regulation in HER2-Positive Breast Cancer
2026-09-04
Labrèche et al. identify a context-dependent mechanism in which FGFR, TGFβ, PKC, and PI3K/AKT signaling jointly regulate periostin expression in Neu-positive breast cancer cells. The study combines tumor models, tissue microarrays, and mechanistic cell experiments to show how epithelial tumor cells acquire a matrix-remodeling phenotype, providing a framework for interpreting pathway crosstalk rather than treating periostin as a simple lineage marker.
Foretinib (GSK1363089) Assay Workflows
2026-09-04
Build more informative cancer assays with Foretinib, a multikinase inhibitor that connects Met and VEGFR pathway biology to tumor cell growth inhibition and motility studies. This workflow separates slowed proliferation from true cell killing, improving interpretation across 2D cultures, migration assays, and cancer metastasis models.
TRIM46 Regulation During Axon Formation
2026-09-03
The reference study reveals that TRIM46 is controlled by coordinated transcriptional, alternative-splicing, nonsense-mediated decay, and protein-stability mechanisms during axon formation. Its findings show how two independently regulated exons create a temporal and neuron-specific switch for TRIM46 protein production, while also refining the model of TRIM46-dependent AnkG organization.
Irinotecan-Induced Steatohepatitis and Fucoidan
2026-09-03
A 2026 study identifies intestinal barrier failure, lipopolysaccharide translocation, and hepatic neutrophil extracellular traps as a connected pathway in CPT-11-induced steatohepatitis. Its findings position fucoidan as a mechanistically informed intervention that preserves gut barrier integrity while limiting downstream liver inflammation.
Lovastatin: From Target Inhibition to Causal Assays
2026-09-02
Lovastatin is an HMG-CoA reductase inhibitor whose effects extend from cholesterol and isoprenoid depletion to proliferation, apoptosis, and macrophage clearance. This article presents a causal assay framework, using the KNUCKLES floral-meristem study to sharpen experimental timing, spatial analysis, and mechanistic interpretation.
Pexidartinib (PLX3397) for TAM Assays
2026-09-02
Pexidartinib (PLX3397) provides a practical way to test how CSF1R dependence shapes macrophage survival, signaling, and tumor-supportive behavior. This workflow positions it as a mechanistic comparator for SPP1-focused strategies rather than as a direct SPP1 inhibitor, helping cancer research teams separate macrophage depletion from phenotype reprogramming.
MAPK10–KRT16 Axis in NSCLC Metastasis
2026-09-01
The reference study identifies MAPK10 as a metastasis-suppressing kinase in non-small cell lung cancer by promoting phosphorylation-dependent RNF213 ubiquitination and proteasomal degradation of KRT16. Its findings connect kinase signaling with intermediate-filament turnover and support the MAPK10/KRT16/RNF213 axis as a candidate prognostic and therapeutic framework, while requiring further validation in clinically diverse models.
Prestained Protein Marker: A Mechanistic QC Guide
2026-08-31
The Prestained Protein Marker is more than a visual ladder: it can create a molecular audit trail for SDS-PAGE and Western blot experiments. This guide connects its EDTA-free, triple-color design to practical interpretation of SepM mutation and signaling data.
Mc-Val-Cit-PABC-PNP ADC Linker: Technical Guide
2026-08-31
Mc-Val-Cit-PABC-PNP is an organic-solvent-compatible cathepsin cleavable ADC peptide linker for antibody-drug conjugate synthesis and lysosomal payload-release research. This guide covers practical handling, storage, analytical checks, and limitations; it is not intended for aqueous, diagnostic, clinical, or therapeutic use.
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-08-30
Azadi and David systematically examined how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Their in vitro model links particle physicochemical properties with energy-dependent endocytosis, providing a useful framework for designing ocular formulations with improved cellular interaction while highlighting the limits of simplified corneal models.
KPT-330: A CRM1 Assay Framework Beyond Oncology
2026-08-29
KPT-330 (Selinexor) is a selective CRM1 inhibitor whose effects extend from nuclear export control to apoptosis, osteoclastogenesis, and tissue remodeling. This guide presents a context-aware assay framework that connects cancer research with emerging osteoarthritis evidence without overstating translational maturity.
Cefotaxime for Reliable Infection-Model Assays
2026-08-29
Learn how Cefotaxime, SKU BA1012, can be incorporated into antimicrobial resistance research and bacterial infection models without confusing antibacterial activity with host-cell toxicity. This scenario-based guide covers assay controls, storage, interpretation, and practical product-selection criteria.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page